Oramed Pharmaceuticals Inc.
ORMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001176309
No open-market purchases or sales by Oramed Pharmaceuticals Inc. insiders were filed in the last 90 days; 84 institutions reported holding it in 13F filings for Q2 2026, worth $80.7M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Oramed Pharmaceuticals Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 61 | 1 | 50 | −10 |
| Shares | 4.26M | 68.9K | 2.28M | −1.92M (−45.7%) |
| Value | $9.29M | $150.3K | $8.16M | −$980.8K (−10.7%) |
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gsa Capital Partners LLP | 164,596 | $589.0K | 0.06% |
| Samson Rock Capital LLP | 36,856 | $131.9K | 0.20% |
| Squarepoint Ops LLC | 34,165 | $122.3K | 0.00% |
| Acadian Asset Management LLC | 31,736 | $113.0K | 0.00% |
| LPL Financial LLC | 16,216 | $58.1K | 0.00% |
| Glass Jacobson Investment Advisors llc | 12,255 | $43.9K | 0.02% |
| American Century Companies Inc | 11,789 | $42.2K | 0.00% |
| Prudential Financial Inc | 11,200 | $40.1K | 0.00% |
| HighTower Advisors, LLC | 10,500 | $39.0K | 0.00% |
| Simplex Trading, LLC | 6,096 | $21.0K | 0.00% |
| Rhumbline Advisers | 1,830 | $6.55K | 0.00% |
| TD Waterhouse Canada Inc. | 1,000 | $3.57K | 0.00% |
| Tyler-Stone Wealth Management | 300 | $1.00K | 0.00% |
Sold out (23)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| XTX Topco Ltd | 151,620 | $330.5K |
| Susquehanna International Group Ltd. | 113,526 | $247.5K |
| Citadel Advisors LLC | 54,162 | $118.1K |
| Corsair Capital Management, L.P. | 47,256 | $103.0K |
| HRT Financial LP | 45,035 | $98.0K |
| Walleye Capital LLC | 36,102 | $78.7K |
| Qube Research & Technologies Ltd | 31,309 | $68.3K |
| Verition Fund Management LLC | 20,550 | $44.8K |
| Apollon Wealth Management, LLC | 20,000 | $43.6K |
| Cambridge Investment Research Advisors, Inc. | 18,372 | $40.0K |
| Diametric Capital, LP | 14,314 | $31.2K |
| Invesco Ltd. | 13,375 | $29.2K |
| Two Sigma Securities, LLC | 12,962 | $28.3K |
| Marshall Wace, LLP | 10,553 | $23.0K |
| Royal Bank of Canada | 10,000 | $22.0K |
| Draper Asset Management, LLC | 5,320 | $11.6K |
| FMR LLC | 1,400 | $3.05K |
| Steward Partners Investment Advisory, LLC | 1,000 | $2.18K |
| Belpointe Asset Management LLC | 800 | $1.74K |
| Federated Hermes, Inc. | 684 | $1.49K |
| Advisory Services Network, LLC | 500 | $1.09K |
| Global Retirement Partners, LLC | 125 | $346 |
| TCI Wealth Advisors, Inc. | 100 | $218 |
Not filed for Q2 2023 yet (1)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| ETF Managers Group, LLC | 68,940 | $150.3K |